MedTrace Logo

Evaluation Of Marginal Bone Height Changes And Biting Force In Screw Retained Implant Prostheses Using Reinforced Resin Vs Monolithic Zirconium

NCT07007572 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-06-06

No results posted yet for this study

Summary

This studies aims to compare the behavior of recently introduced resin reinforces compared to monolithic zirconia

Conditions

  • Biting Forces
  • Bone; Change, Diabetic (Manifestation)
  • Color Stability
  • Disorder of Soft Tissue
  • Prosthetic Complications
  • Bacterial Overgrowth

Interventions

COMBINATION_PRODUCT

Digitally-fabricated implant supported supra-structure fabricated from reinforced resin

A comprehensive clinical examination with an understanding of patients' chief complaints and needs will be carried out. For each patient, two implants will be placed in the edentulous area, and the patient will receive a screw-retained bridge supported by both implants made of milled monolithic zirconia (Dental Direkt Zirconia, Germany). After 6 months, the zirconia restoration will be replaced with a milled resin-reinforced composite (Nanoska G Plus, USA), allowing the same patient to use the new restoration for another 6 months. Randomization will be performed to determine the sequence of bridge material for each participant. Accordingly, the two restorations will be sequentially delivered to each participant with no gap (wash-up period) between them. Consent will be signed by the selected participants after explaining the detailed information of the trial.

COMBINATION_PRODUCT

Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia

Digitally-fabricated implant supported supra-structure fabricated from monolithic zirconia

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2026-01-01
Completion
2026-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07007572 on ClinicalTrials.gov